Quibron

Active Ingredient(s): Guaifenesin + Theophylline
Category: Asthma



Quibron Overview

Guaifenesin INN /wafnsn/ or guaiphenesin (former BAN), also glyceryl guaiacolate,[2] is an expectorant drug sold over the counter and usually taken orally to assist the bringing up (expectoration) of phlegm from the airways in acute respiratory tract infections. Contents 1 Medical use 2 Side-effects 3 Mechanism of action 4 History 5 Availability 6 Veterinary use 7 Research 8 See also 9 References 10 External links Medical use Guaifenesin is used to control cough and is sometimes c...

Read more Quibron Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Guaifenesin

Recent Quibron Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Guaifenesin + Theophylline
  • Capsule: 180mg + 300mg, 90mg + 150mg
  • Elixir: 100mg/15ml + 300mg/15ml
  • Liquid: 100mg/15ml + 100mg/15ml, 100mg/15ml + 300mg/15ml, 90mg/15ml + 150mg/15ml
  • Syrup: 90mg/15ml + 150mg/15ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (262 results)


Possibly related Quibron Topics:

severe copd and quibron 300 Just wondering if this medication would help with my breathing. I am currrently on symbicort and duo neb. Plus I use atr... 1 reply




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2017 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 20 August 2017.

We are committed to your privacy.

Copyright © 2005-2017 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.